<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VES</journal-id>
<journal-id journal-id-type="hwp">spves</journal-id>
<journal-id journal-id-type="nlm-ta">Vasc Endovascular Surg</journal-id>
<journal-title>Vascular and Endovascular Surgery</journal-title>
<issn pub-type="ppub">1538-5744</issn>
<issn pub-type="epub">1938-9116</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1538574413478474</article-id>
<article-id pub-id-type="publisher-id">10.1177_1538574413478474</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Controversy Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Vascular Endostapling Systems for Vascular Endografts (T)EVAR—Systematic Review—Current State</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bail</surname>
<given-names>Dorothee H. L.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1538574413478474">1</xref>
<xref ref-type="corresp" rid="corresp1-1538574413478474"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walker</surname>
<given-names>Tobias</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-1538574413478474">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giehl</surname>
<given-names>Johannes</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1538574413478474">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1538574413478474">
<label>1</label>KCQ - Competence-Center Quality Assurance, Medical Service of Statutory Healthcare Insurance, Tuebingen, Germany</aff>
<aff id="aff2-1538574413478474">
<label>2</label>Department of Thoracic-, Cardiac- and Vascular Surgery, University Hospital Tuebingen, Tuebingen, Germany</aff>
<author-notes>
<corresp id="corresp1-1538574413478474">Dorothee H. L. Bail, KCQ Competence-Center Quality Assurance, Bismarckstr.96, 72072 Tübingen, Germany. Email: <email>dorotheebail@t-online.de</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>47</volume>
<issue>4</issue>
<fpage>261</fpage>
<lpage>266</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec>
<title>Purpose:</title><p>Recently, vascular endostapling systems were developed to achieve better sealing at the proximal neck of the aneurysm and to prevent endograft migration. The purpose of this study was to provide a systematic review about the current state and possible options of vascular endostapling systems.</p></sec>
<sec>
<title>Results:</title><p>No randomized controlled trials were published. The results showed that the use of an endostaple system considerably reduced the rates of endoleaks type 1a and endograft migration. Regarding the use of endostaples in different types of endografts, only a few results were available.</p></sec>
<sec>
<title>Conclusion:</title><p>The results are not conclusive. With endostaple systems, patients with difficult anatomic features and high risk can potentially be treated. These systems might reduce the high reintervention rates after endovascular aneurysm repair. Controlled randomized trials with larger number of patients are warranted with endostapling use in primary endograft implantation and for use in reintervention for late endoleaks or endograft migrations.</p></sec>
</abstract>
<kwd-group>
<kwd>endovascular stapling</kwd>
<kwd>vascular endograft</kwd>
<kwd>endograft migration</kwd>
<kwd>EVAR</kwd>
<kwd>TEVAR</kwd>
<kwd>endostaples</kwd>
<kwd>endoleak</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1538574413478474">
<title>Introduction</title>
<p>The proximal endograft fixation has a decisive influence on the success and durability of endovascular aneurysm treatment (thoracic/endovascular aneurysm repair [T/EVAR]). Due to the longitudinal migration or radial dilatation of the proximal aneurysm neck in the area of the proximal endograft fixation, endoleak type 1a can occur. The aneurysm neck anatomy—&gt;28 mm diameter and &gt;60° angulation—and a short landing zone play a major role in the occurrence of endoleak type 1a. Aortic neck dilatation (AND) or enlargement results in endoleak type 1a after (T)EVAR and late aneurysm rupture or open surgical repair.<sup>
<xref ref-type="bibr" rid="bibr1-1538574413478474">1</xref>
</sup>
</p>
<p>The rate of occurrence of endoleaks type 1 after EVAR is 15% to 52% and after TEVAR is 21%.<sup>
<xref ref-type="bibr" rid="bibr2-1538574413478474">2</xref><xref ref-type="bibr" rid="bibr3-1538574413478474"/>–<xref ref-type="bibr" rid="bibr4-1538574413478474">4</xref>
</sup> Endograft migration, reported at 2.3% to 9.5%, is strongly associated with proximal fixation and anatomy of the aneurysm neck. An AND &gt;10% and a preoperative aortic diameter &gt;5.5 cm are independent risk factors for stent graft migration.<sup>
<xref ref-type="bibr" rid="bibr5-1538574413478474">5</xref>
</sup> Recently, Pintoux et al found that the absence of proximal stent graft fixation of the proximal aneurysm neck enhances proximal migration.<sup>
<xref ref-type="bibr" rid="bibr6-1538574413478474">6</xref>
</sup> Progredient degeneration and arteriosclerosis of the aortic wall further influence late endograft migration. The reintervention rate after (T)EVAR varies between 13% and 30%.<sup>
<xref ref-type="bibr" rid="bibr1-1538574413478474">1</xref>,<xref ref-type="bibr" rid="bibr7-1538574413478474">7</xref>
</sup> Studies have reported different methods for endoleak treatment.<sup>
<xref ref-type="bibr" rid="bibr1-1538574413478474">1</xref>,<xref ref-type="bibr" rid="bibr8-1538574413478474">8</xref>
<xref ref-type="bibr" rid="bibr9-1538574413478474"/>
<xref ref-type="bibr" rid="bibr10-1538574413478474"/>–<xref ref-type="bibr" rid="bibr11-1538574413478474">11</xref>
</sup> According to the Society of Vascular Surgery and the European Society of Vascular Surgery guidelines, endoleaks type 1 have to be treated<sup>
<xref ref-type="bibr" rid="bibr12-1538574413478474">12</xref><xref ref-type="bibr" rid="bibr13-1538574413478474"/>–<xref ref-type="bibr" rid="bibr14-1538574413478474">14</xref>
</sup> as well as endograft migration &gt;10 mm or movement of ≤10 mm.<sup>
<xref ref-type="bibr" rid="bibr15-1538574413478474">15</xref>
</sup> Recently, endovascular stapling systems were developed to fixate endografts to prevent endgraft migration and endoleakage. With transcatheter techniques, metal spirals or “anchors” were used to connect the native aortic wall with the covered part of the endograft. Two differently designed systems have been tested in humans the Endostaple system EndoRefix (Lombard Medical, Oxfordshire, UK) and Aptus HeliFX System (Aptus HeliFX Aortic Securement System; Aptus Endosystems, Inc, Sunnyvale, California). The EndoRefix System uses Nitinolclips<sup>
<xref ref-type="bibr" rid="bibr16-1538574413478474">16</xref>
</sup> and the Aptus HeliFX System uses helical metal staples (3.0 mm diameter and 4.5 mm length; <xref ref-type="fig" rid="fig1-1538574413478474">Figures 1</xref> and <xref ref-type="fig" rid="fig2-1538574413478474">2</xref>). In both systems, the covered part of the endograft and the native aortic wall are penetrated up to the adventitia of the native aortic wall. Furthermore, a device for endovascular stapling (endovascular stapler) has been developed by ES Vascular Ltd (Haifa Bay, Israel). Despite CE certification was obtained for this device no treatment results are published.</p>
<fig id="fig1-1538574413478474" position="float">
<label>Figure 1.</label>
<caption>
<p>The helical endoanchor of the HeliFX Aortic Securement System (3 mm diameter and 4.5 mm total length; with kind permission of Aptus Endosystems, Inc, Sunnyvale, California).</p>
</caption>
<graphic xlink:href="10.1177_1538574413478474-fig1.tif"/>
</fig>
<fig id="fig2-1538574413478474" position="float">
<label>Figure 2.</label>
<caption>
<p>Endovascular application of the helical endostaples (with kind permission of Aptus Endosystems, Inc, Sunnyvale, California).</p>
</caption>
<graphic xlink:href="10.1177_1538574413478474-fig2.tif"/>
</fig>
<p>This study aims to systematically review the current state and results of endovascular endostapling and its potential benefits in endovascular aneurysm repair.</p>
</sec>
<sec id="section2-1538574413478474" sec-type="methods">
<title>Method</title>
<p>For the literature search, various databases (Cochrane Library, Medline, and common search engines) were systematically searched using the following search terms: “vascular endostaple,” “endostapling,” “EVAR,” “endostaple,” “endograft,” “endoleaks,” and “endoanchor.” Google search resulted in 2 Congress abstracts from March and June 2012. A total of 15 publications, which were initially evaluated independently for their evidence classification, were included for evaluation.</p>
</sec>
<sec id="section3-1538574413478474">
<title>Results</title>
<p>There had been 6 basic researches, 3 case reports, 3 observational studies, and 3 publications about the results of STAPLE trials (<xref ref-type="table" rid="table1-1538574413478474">Table 1</xref>) identified. The clinical STAPLE-1 trial was designed to demonstrate the safety and feasibility of the Aptus HeliFX Aortic Securement System with the use of the aptus endograft. In the phase I study (STAPLE-1), 21 patients were enrolled at 5 US institutions.</p>
<table-wrap id="table1-1538574413478474" position="float">
<label>Table 1.</label>
<caption>
<p>All Identified Publications About Endostaple Systems.</p>
</caption>
<graphic alternate-form-of="table1-1538574413478474" xlink:href="10.1177_1538574413478474-table1.tif"/>
<table>
<thead>
<tr>
<th>No.</th>
<th>Author</th>
<th>Study Type</th>
<th>Number of Cases (n)</th>
<th>Staple System</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Higgins et al<sup>
<xref ref-type="bibr" rid="bibr17-1538574413478474">17</xref>
</sup>
</td>
<td>Experimental</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td>2</td>
<td>Melas et al<sup>
<xref ref-type="bibr" rid="bibr18-1538574413478474">18</xref>
</sup>
</td>
<td>Experimental</td>
<td>5</td>
<td>Aptus Endosystems</td>
</tr>
<tr>
<td>3</td>
<td>Trout et al<sup>
<xref ref-type="bibr" rid="bibr19-1538574413478474">19</xref>
</sup>
</td>
<td>Animal (sheep and calves)</td>
<td>NN</td>
<td>N/A</td>
</tr>
<tr>
<td>4</td>
<td>Trout et al<sup>
<xref ref-type="bibr" rid="bibr20-1538574413478474">20</xref>
</sup>
</td>
<td>Animal (calves)</td>
<td>7</td>
<td>N/A</td>
</tr>
<tr>
<td>5</td>
<td>Ohtake et al<sup>
<xref ref-type="bibr" rid="bibr21-1538574413478474">21</xref>
</sup>
</td>
<td>Animal (pigs)</td>
<td>5</td>
<td>T-Fix</td>
</tr>
<tr>
<td>6</td>
<td>Murphy et al<sup>
<xref ref-type="bibr" rid="bibr22-1538574413478474">22</xref>
</sup>
</td>
<td>Animal (ovine)</td>
<td>NN</td>
<td>EndoRefix</td>
</tr>
<tr>
<td>7</td>
<td>Ohki et al<sup>
<xref ref-type="bibr" rid="bibr23-1538574413478474">23</xref>
</sup>
</td>
<td>Case report</td>
<td>2</td>
<td>Aptus HeliFX</td>
</tr>
<tr>
<td>8</td>
<td>Gandhi and Katzen<sup>
<xref ref-type="bibr" rid="bibr24-1538574413478474">24</xref>
</sup>
</td>
<td>Case report</td>
<td>1</td>
<td>Aptus HeliFX</td>
</tr>
<tr>
<td>9</td>
<td>de Vries et al<sup>
<xref ref-type="bibr" rid="bibr25-1538574413478474">25</xref>
</sup>
</td>
<td>Case report</td>
<td>2</td>
<td>Aptus HeliFX</td>
</tr>
<tr>
<td>10</td>
<td>Donas et al<sup>
<xref ref-type="bibr" rid="bibr26-1538574413478474">26</xref>
</sup>
</td>
<td>Observational report</td>
<td>8</td>
<td>EndoRefix</td>
</tr>
<tr>
<td>11</td>
<td>Donas et al<sup>
<xref ref-type="bibr" rid="bibr27-1538574413478474">27</xref>
</sup>
</td>
<td>Observational report</td>
<td>8</td>
<td>EndoRefix</td>
</tr>
<tr>
<td>12</td>
<td>Avci et al<sup>
<xref ref-type="bibr" rid="bibr28-1538574413478474">28</xref>
</sup>
</td>
<td>Observational report</td>
<td>11</td>
<td>Aptus HeliFX</td>
</tr>
<tr>
<td>13</td>
<td>Deaton et al<sup>
<xref ref-type="bibr" rid="bibr29-1538574413478474">29</xref>
</sup>
</td>
<td>STAPLE-1 Interventional (prospective, nonrandomized, multicenter)</td>
<td>21</td>
<td>Aptus HeliFX</td>
</tr>
<tr>
<td>14</td>
<td>Gomero-Cure et al<sup>
<xref ref-type="bibr" rid="bibr30-1538574413478474">30</xref>
</sup>
</td>
<td>STAPLE-2 Interventional (prospective, nonrandomized, multicenter)</td>
<td>155</td>
<td>Aptus HeliFX</td>
</tr>
<tr>
<td>15</td>
<td>Mehta et al<sup>
<xref ref-type="bibr" rid="bibr31-1538574413478474">31</xref>
</sup>
</td>
<td>STAPLE-2 Interventional (prospective, nonrandomized, multicenter)</td>
<td>155</td>
<td>Aptus HeliFX</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1538574413478474">
<p>Abbreviation: N/A, not available.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The Food and Drug Administration-approved phase II (STAPLE-2; IDE NCT00507559) study is a prospective, nonrandomized, multicenter clinical study to evaluate the safety and effectiveness of the Aptus HeliFX Aortic Securement System System compared to an open surgical repair historical control group in the treatment of abdominal aortic aneurysms (AAAs).<sup>
<xref ref-type="bibr" rid="bibr32-1538574413478474">32</xref>
</sup>
</p>
<sec id="section4-1538574413478474">
<title>Basic Research</title>
<p>In a preliminary study, Higgins et al reported the technical simulation of the insertion of an endostaple into a vascular stent and an artery.<sup>
<xref ref-type="bibr" rid="bibr17-1538574413478474">17</xref>
</sup> Helical nitinol wires were straightened out and inserted intraluminal with an optical cable (application device). After the removal of the endostaple, the wires were twisted into a bifilar helix. Recently, Melas et al reported the Aptus HeliFX System for endograft fixation in an experimental model using human cadaveric aortas.<sup>
<xref ref-type="bibr" rid="bibr18-1538574413478474">18</xref>
</sup> Using endografts of 5 different manufacturers, they compared the force required to dislocate the endograft at the proximal neck (displacement force [DF]) with conventionally hand sewn anastomoses, no fixation, and the Aptus-Endostaple System. The hand suture showed the highest DF (150 N), the endografts fixated with the Aptus-Endostaple System showed a DF of 49 to 79 N (depending on the numbers of endostaples used), and the endograft without additionally fixation reached only 19 DF. The authors summarized a significant better fixation after application of endostaples.</p>
<p>Trout et al described preliminary in vivo tests with helical vascular endostaples in sheep and calves and showed that a short Dacron segment could be securely fixated to the native thoracic aortic wall.<sup>
<xref ref-type="bibr" rid="bibr19-1538574413478474">19</xref>
</sup> In a further study, Trout demonstrated endostaple-related thrombogenesis and tissue ingrowth in 11 calves over a period of 30 and 90 days. He compared a 5-0 polypropylene suture with a segment of solely endostaple fixation at the proximal anastomosis of a Dacron prosthesis. The histopathological examination showed a good tissue ingrowth throughout all the endostaples and no residual thrombus on the suture line or on the endostaples. The inflammatory changes were equal between the suture line and the endostaples, which was typical for a healing graft. No endostaple failure or endograft migration was reported.<sup>
<xref ref-type="bibr" rid="bibr20-1538574413478474">20</xref>
</sup> Murphy et al<xref ref-type="bibr" rid="bibr22-1538574413478474">22</xref> tested an endovascular stapling system in an animal model. Nitinol wires (no details were provided about the producer) were used (most likely they used the later commercially available EndoRefix System), which were contraindicated in polytetrafluoroethylene grafts.<sup>
<xref ref-type="bibr" rid="bibr22-1538574413478474">22</xref>
</sup> The endograft was fixated proximal and distal with endostaples. No complications, endograft migration, or staple dislocation was observed for over 35 days. These staples could be removed and replaced. Moreover, 89% of the implanted staples showed a full penetration of the endograft and vessel wall through the adventitia and showed an endothelialization without any thrombus. Although the endostaples were designed only for proximal fixation, Murphy and his colleagues also used them at the distal part of the endograft. In a very unconventional study, Ohtake et al used a T-Fix suturing device (Smith &amp; Nephew Co, Ltd, London, UK) in 5 pigs for endovascular repair of an endoleak type 1 in thoracic aortic aneurysm. The T-Fix device, commonly used for all-inside meniscal repair, was successfully implanted in all the 5 animals, resulting in the removal of endoleaks. The histopathological examination showed precise attachment of the T-Fix system with the penetration of the stent graft and the native aortic wall.<sup>
<xref ref-type="bibr" rid="bibr21-1538574413478474">21</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section5-1538574413478474">
<title>Case Reports</title>
<p>Ohki et al reported the first-in-man application of the Aptus HeliFX System in 2 patients.<sup>
<xref ref-type="bibr" rid="bibr23-1538574413478474">23</xref>
</sup> Both the patients were high-risk patients for open aneurysm repair (OAR) of an AAA. In both the patients, an Aptus modular endograft with concomitant use of endostaples was implanted. Acute technical success was achieved in both the patients. One patient had no evidence of a perioperative endoleak. In the other patient, an early perioperative endoleak type 1a occurred. Only 4 endostaples were used in this patient and the computed tomography examination showed that the graft was not applied close to the aortic wall. Three additional endostaples were implanted in the posterior segment of the endograft, and the final examination showed no endoleak. There were no device-related complications in a 1-year follow-up and a sac shrinkage of 11% and 16% were observed. Moreover, the proximal neck angulation reduced to 13% and no stent graft migration occurred. In a single case report, Gandhi et al reported a 80-year-old patient with AAA with a primary endoleak after a Zenith Flex AAA stent graft (Cook Medical Inc, Bloomington, Indiana), which could not be managed with balloon dilatation. Due to the short neck of the aneurysm, there was not enough length for an aortic cuff. After implantation of 6 endostaples of the Aptus HeliFX System, no endoleak was detected.<sup>
<xref ref-type="bibr" rid="bibr24-1538574413478474">24</xref>
</sup> de Vries et al reported another successful repair with the Aptus HeliFX System in 2 cases with late endograft migration and type 1 endoleak in a 10 years follow-up after a Talent and AneurRx endograft implantation.<sup>
<xref ref-type="bibr" rid="bibr25-1538574413478474">25</xref>
</sup> In the short-term follow-up after 6 months, no endostapling complications, further endograft-migration of the primary endograft, or of the proximal cuff occurred.</p>
<sec id="section6-1538574413478474">
<title>Observational Studies</title>
<p>Two publications of the same center reported about the Endostaple EndoRefix System<sup>
<xref ref-type="bibr" rid="bibr26-1538574413478474">26</xref>,<xref ref-type="bibr" rid="bibr27-1538574413478474">27</xref>
</sup> in 8 patients with AAA after either Zenith or Talent endograft implantation. The studies showed that 69% of 29 endostaples were successfully placed, and 31% of the endostaples were not fully penetrated and were retracted due to severe calcification of the aortic wall. No staple embolization was observed. The advantage of these endostaples is that they can be retracted into the device after their release. However, the trial of the EndoRefix System was stopped due to insufficient resources and is currently not available (Company business decision, IDE closed, no commercialization planned).<sup>
<xref ref-type="bibr" rid="bibr16-1538574413478474">16</xref>
</sup> Avci et al from the working group of de Vries, reported prospectively and retrospectively (from 9 centers) about 11 patients (mean age of 77 years) with primary failed endograft due to migration with and without endoleak type 1a and the use of the Aptus HeliFX System.<sup>
<xref ref-type="bibr" rid="bibr28-1538574413478474">28</xref>
</sup> The system was used for repair in different endograft types (2 Excluder, 1 AneurRX, and 8 Talent). Most of the patients got additional extender cuffs with suprarenal fixation, and an average of 6 endostaples were implanted. In a 10-month follow-up, no Endostaple-related complication or a renewed endograft migration had occurred. Two patients required reintervention due to persisting endoleak type 1.</p>
</sec>
<sec id="section7-1538574413478474">
<title>Results of the STAPLE-1 and -2 Trials</title>
<p>Three studies showed the results of the only currently available vascular Endostapling system Aptus HeliFX in a total of 176 patients after AAA.<sup>
<xref ref-type="bibr" rid="bibr29-1538574413478474">29</xref>
<xref ref-type="bibr" rid="bibr30-1538574413478474"/>–<xref ref-type="bibr" rid="bibr31-1538574413478474">31</xref>
</sup> All 3 publications were of the working group from the Division of Vascular Surgery, Georgetown University, Washington, District of Columbia. Detailed technical description and implantation techniques can be found in the 2 publications of Deaton et al.<sup>
<xref ref-type="bibr" rid="bibr16-1538574413478474">16</xref>,<xref ref-type="bibr" rid="bibr29-1538574413478474">29</xref>
</sup> The system was proved in an initial multicenter “safety and feasibility” study (STAPLE-1) on 21 patients of mean age 75 years, with a follow-up of 6 and 12 months.<sup>
<xref ref-type="bibr" rid="bibr29-1538574413478474">29</xref>
</sup> Only 1 patient was female and 57% of the patients had severe comorbidities. The diameter of the AAA was 50 to 58 mm in 67% of the patients, 59 to 60 mm in 15%, and 80 to 89 mm in 10% of the patients. Technical success was 99% and major adverse events (MAEs) occurred in 14 (66%) of 21 patients. The complications resulted due to the implantation device of the Aptus endograft and not the Endostaple device. Proximal cuff extension was used in 2 patients; 1 patient required a limb extension. In 3 patients, limb thrombosis occurred related to the endograft. In all, 3 patients had bleeding complications, 2 had not-specified aortic and vascular complications, and 8 had no device-related complications within 30 days. The MAE rate after 6 months was 23.8% and after 1 year was 28.6% (4 of 14 patients). The secondary end point of the study, that is freedom of early endoleak type 1 or 3, was 0% to 1%. Four patients had an early endoleak type 2 and none reported late endoleaks of type 1, 3, or 4. Endograft migration occurred in 0% to 1%. A reduction of the aneurysm sac, as a criterion of sufficient aneurysm repair, could be reached in 69.2% of the 14 patients in the follow-up. No aneurysm rupture was observed in the follow-up.</p>
<p>In two 2012 Congress abstracts, the actual 2-year results of the STAPLE-2 trial are reported.<sup>
<xref ref-type="bibr" rid="bibr30-1538574413478474">30</xref>,<xref ref-type="bibr" rid="bibr31-1538574413478474">31</xref>
</sup>
</p>
<p>Mehta et al reported about the pivotal study (STAPLE-2); the Aptus HeliFX System was implanted in 24 centers in 155 patients (24 months follow-up) with a technical success of 99% (153 patients).<sup>
<xref ref-type="bibr" rid="bibr31-1538574413478474">31</xref>
</sup> A total of 180 staples were implanted, that is a mean of 5.5 staples in each patient. The primary end point, safety and efficiency, was reached in 98%. Not-specified thrombus-related events (TRE) occurred in 43.8% of the patients. In the 2-year follow-up, a TRE rate of 34.8% in 52 interventions was observed in 49 patients without any amputation or death, which was addressed to a manufacturing discrepancy. An early endoleak type 1 occurred in 1 patient who did not fulfill the proximal neck criteria (internal diameter between 19 and 29 mm and at least 12 mm length of proximal nonaneurysmal neck). An early type 3 endoleak was described in 1 patient with unstapled aortic cuff. Late endoleak types 1 and 3, staple dislocation, or the need of intervention were not observed. Due to elongation of the proximal neck, a endograft migration in 2 patients was noted. A reduction in the aneurysm diameter in 72.5%, stable diameters in 22%, and an increase in diameter was seen in 3% of the treated patients. All patients with increase in diameters had endoleaks type 3. In the 2-year follow-up, no AAA ruptures, AAA-related death, or stent fractures were reported. Nothing was said about the completeness of the data.</p>
<p>Gomero-Cure et al also reported the same patient panel of the phase II of the STAPLE-2 trial.<sup>
<xref ref-type="bibr" rid="bibr30-1538574413478474">30</xref>
</sup> Data were available after a mean of 24 months (data after 6 months of 141 [91%] patients and after 24 months of 106 [63.4%] patients). After 2 years, AND &gt;15% (compared with the diameter at 1 month postoperatively) occurred in 4.7% of the patients (n = 5). An AND &gt;10% of the diameter of the endoprothesis did not occur (0%). There were no late endoleaks type 1 or aneurysm ruptures. Gomero-Cure et al reported 1 endograft migration during the 2-year follow-up,<sup>
<xref ref-type="bibr" rid="bibr30-1538574413478474">30</xref>
</sup> whereas Mehta et al reported 2 patients with endograft migration from the same working group.<sup>
<xref ref-type="bibr" rid="bibr31-1538574413478474">31</xref>
</sup> Aortic neck stability, defined as AND &lt;15%, was documented in 95.3% of all the patients (n = 101).<sup>
<xref ref-type="bibr" rid="bibr30-1538574413478474">30</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section8-1538574413478474">
<title>Discussion</title>
<p>Few studies are nonrandomized prospective or retrospective observational studies. Some are technical descriptions that showed a good feasibility of the endovascular staples in experimental or animal models. Type 1a endoleak and endograft migration are 2 main complications of (T)EVAR.<sup>
<xref ref-type="bibr" rid="bibr1-1538574413478474">1</xref>
</sup> Although the results referring endoleakage and endograft migration of the new endografts have improved compared to the first generation, Avgerinos et al reported that endograft migration still occurred in 3% to 28% of the patients after EVAR.<sup>
<xref ref-type="bibr" rid="bibr33-1538574413478474">33</xref>
</sup> In long-term follow-ups (&gt;12 months), endoleaks type 1 and 3 occurred with an incidence of 1% to 38%.<sup>
<xref ref-type="bibr" rid="bibr34-1538574413478474">34</xref>
<xref ref-type="bibr" rid="bibr35-1538574413478474"/>
<xref ref-type="bibr" rid="bibr36-1538574413478474"/>
<xref ref-type="bibr" rid="bibr37-1538574413478474"/>–<xref ref-type="bibr" rid="bibr38-1538574413478474">38</xref>
</sup> However, controlled trials with larger number of patients, long-term results, and comparison of different endograft types are not available. The rate of early endoleaks type 1 was low in both endostaple systems (0%-0.64%), which is comparable to the 30-day results of endograft aneurysm repair without endostapling.<sup>
<xref ref-type="bibr" rid="bibr37-1538574413478474">37</xref>
<xref ref-type="bibr" rid="bibr38-1538574413478474"/>
<xref ref-type="bibr" rid="bibr39-1538574413478474"/>–<xref ref-type="bibr" rid="bibr40-1538574413478474">40</xref>
</sup> The 2-year follow-up data about the migration rate in the Aptus HeliFX are low with a value of 1.9% in 109 patients.</p>
<p>The clinical relevance of endoleak type 1 and AND is still controversially discussed in the literature.<sup>
<xref ref-type="bibr" rid="bibr41-1538574413478474">41</xref>
</sup> The rates of AND after EVAR varies between 0% and 28% in a 2-year follow-up and up to 59% in a 5-year follow-up.<sup>
<xref ref-type="bibr" rid="bibr42-1538574413478474">42</xref>,<xref ref-type="bibr" rid="bibr43-1538574413478474">43</xref>
</sup> Defining AND as an increase of &gt;15% increase in the neck diameter, AND rates are reported between 24.9% and 35% after 2 and 5 years of endograft implantation, respectively.<sup>
<xref ref-type="bibr" rid="bibr41-1538574413478474">41</xref>,<xref ref-type="bibr" rid="bibr44-1538574413478474">44</xref>
</sup> The AND rate, after the use of Endostaples, was very low with 4.7% in a 2-year follow-up. The implantation of an extender cuff as a unique therapy is not recommended because of migration risks, which can lead to Endoleak type 3.<sup>
<xref ref-type="bibr" rid="bibr25-1538574413478474">25</xref>
</sup> Avci et al showed persisting endoleaks in 2 of 11 patients after the repair of a secondary endoleak using endostaples and endocuffs.<sup>
<xref ref-type="bibr" rid="bibr28-1538574413478474">28</xref>
</sup> The MAE rate after the use of endostapling systems was high with 34%; however, a majority of the MAEs were implantation device related and not endostaple/endoanchor related, with a lack of further details. Conversion to OAR after the use of endostaples is possible without higher risks.<sup>
<xref ref-type="bibr" rid="bibr28-1538574413478474">28</xref>
</sup> The high TRE rates after vascular endostapling must be evaluated. Further research should be conducted on the size of circumferential thrombus at the infrarenal aneurysm neck, severe aortic wall calcification, and endoleakage due to undersized endografts. A limitation of endostapling systems is that only a gap of &lt;2 mm of the 2 main structures—the aortic wall and the endograft—can be connected (this applies for the Aptus HeliFX System).<sup>
<xref ref-type="bibr" rid="bibr28-1538574413478474">28</xref>
</sup> The additional cost of the currently available Endostapling system HeliFX is about 5400 Euros (Information of the European Distributor CoRRect Medical GmbH, Deisenhofen, Germany). In April 2012, the Aneurysm treatment using Aortic Securement System global Registry started patient recruitment. The registry has 2 arms for endostaple use in primary endograft implantation and for use in reintervention/revision. The HeliFX System can be used in different endograft types (Cook Medical Inc; W.L. Gore &amp; Associates Inc, Minneapolis, Minnesota; and Medtronic Inc, Minneapolis, Minnesota). About 75 centers in the United States and Europe would participate in the registry, with 1000 patients in each arm of the registry. A follow-up of 5 years is planned.</p>
</sec>
<sec id="section9-1538574413478474">
<title>Conclusion</title>
<p>The low rates of AND and endoleak type 1 with the use of endostaple systems in primary implantation of endografts are promising. However, further research for long-term results with a larger number of patients is warranted, because the benefit of endostapling in specific indications has still to be proven. For example, historical comparison is possible and can be demanded.</p>
<p>The most frequent endoleaks of type 1 depend on the proximal aneurysm neck and on the landing zone of the aneurysm. Endostaple systems can reduce the radial dilatation of the aorta in the area<sup>
<xref ref-type="bibr" rid="bibr30-1538574413478474">30</xref>
</sup> due to the connection of the native aortic wall with the endograft similar to hand suturing. With the use of endostaple systems, the reintervention rate and OAR conversion may be reduced.</p>
<p>Only preliminary results on the use of endostaple systems in different types of endografts or as a reintervention in late endoleaks type 1 are available; however, the benefit of endostaples seems to be independent of the endograft types.<sup>
<xref ref-type="bibr" rid="bibr29-1538574413478474">29</xref>
</sup> Endostaple systems might reduce the high costs due to the high reintervention rates after endovascular repair. Although the endostaple systems are designed for use at the proximal neck/landing zone of the endograft, other application areas, such as distal fixation, may be possible.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1538574413478474">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1538574413478474">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1538574413478474">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghouri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krajcer</surname>
<given-names>Z</given-names>
</name>
</person-group>. <article-title>Endoluminal abdominal aortic aneurysm repair: the latest advances in prevention of distal endograft migration and type 1 endoleak</article-title>. <source>Tex Heart Inst J</source>. <year>2010</year>;<volume>37</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr2-1538574413478474">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Tracci</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sabri</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Real-world experience with type I endoleaks after endovascular repair of the thoracic aorta</article-title>. <source>Am Surg</source>. <year>2010</year>;<volume>76</volume>(<issue>6</issue>):<fpage>599</fpage>–<lpage>605</lpage>.</citation>
</ref>
<ref id="bibr3-1538574413478474">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alsac</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Khantalin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Julia</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The significance of endoleaks in thoracic endovascular aneurysm repair</article-title>. <source>Ann Vasc Surg</source>. <year>2011</year>;<volume>25</volume>(<issue>3</issue>):<fpage>345</fpage>–<lpage>351</lpage>.</citation>
</ref>
<ref id="bibr4-1538574413478474">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heikkinen</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Arko</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Zarins</surname>
<given-names>CK.</given-names>
</name>
</person-group> <article-title>What is the significance of endoleaks and endotension</article-title>. <source>Surg Clin North Am</source>. <year>2004</year>;<volume>84</volume>(<issue>5</issue>):<fpage>1337</fpage>–<lpage>1352</lpage>, <fpage>vii</fpage>.</citation>
</ref>
<ref id="bibr5-1538574413478474">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Verzini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zannetti</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Device migration after endoluminal abdominal aortic aneurysm repair: analysis of 113 cases with a minimum follow-up period of 2 years</article-title>. <source>J Vasc Surg</source>. <year>2002</year>;<volume>35</volume>(<issue>2</issue>):<fpage>229</fpage>–<lpage>235</lpage>.</citation>
</ref>
<ref id="bibr6-1538574413478474">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pintoux</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chaillou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Azema</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term influence of suprarenal or infrarenal fixation on proximal neck dilatation and stentgraft migration after EVAR</article-title>. <source>Ann Vasc Surg</source>. <year>2011</year>;<volume>25</volume>(<issue>8</issue>):<fpage>1012</fpage>–<lpage>1019</lpage>.</citation>
</ref>
<ref id="bibr7-1538574413478474">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sybrandy</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Buth</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Endovascular repair of abdominal aortic aneurysms with concomitant common iliac artery aneurysm: outcome analysis of the EUROSTAR Experience</article-title>. <source>J Endovasc Ther</source>. <year>2008</year>;<volume>15</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr8-1538574413478474">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KH</given-names>
</name>
<etal/>
</person-group>. <article-title>Treatment of type I endoleaks after endovascular aneurysm repair of infrarenal abdominal aortic aneurysm: usefulness of N-butyl cyanoacrylate embolization in cases of failed secondary endovascular intervention</article-title>. <source>J Vasc Interv Radiol</source>. <year>2011</year>;<volume>22</volume>(<issue>2</issue>):<fpage>155</fpage>–<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr9-1538574413478474">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>JX</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>QS</given-names>
</name>
<name><surname>Jing</surname><given-names>ZP</given-names></name><etal/> 
</person-group>. <article-title>[Fibrin glue embolization treating intra-operative type I endoleak of endovascular repair of abdominal aortic aneurysm: long-term result]</article-title>. <source>Zhonghua Wai Ke Za Zhi</source>. <year>2011</year>;<volume>49</volume>(<issue>10</issue>):<fpage>883</fpage>–<lpage>887</lpage>.</citation>
</ref>
<ref id="bibr10-1538574413478474">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Treatment of type I endoleak after endovascular repair of infrarenal abdominal aortic aneurysm: success of fibrin glue sac embolization</article-title>. <source>J Endovasc Ther</source>. <year>2010</year>;<volume>17</volume>(<issue>6</issue>):<fpage>687</fpage>–<lpage>693</lpage>.</citation>
</ref>
<ref id="bibr11-1538574413478474">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Treatment of endoleaks: techniques and outcome</article-title>. <source>J Cardiovasc Surg (Torino)</source>. <year>2012</year>;<volume>53</volume>(<issue>1 suppl 1</issue>):<fpage>91</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr12-1538574413478474">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moll</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Fraedrich</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>;<volume>41</volume>(<issue>suppl 1</issue>):<fpage>S1</fpage>–<lpage>S58</lpage>.</citation>
</ref>
<ref id="bibr13-1538574413478474">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fransen</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Vallabhaneni</surname>
<given-names>SR</given-names>
<suffix>Sr</suffix>
</name>
<name>
<surname>van Marrewijk</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Laheij</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Buth</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Rupture of infra-renal aortic aneurysm after endovascular repair: a series from EUROSTAR registry</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2003</year>;<volume>26</volume>(<issue>5</issue>):<fpage>487</fpage>–<lpage>493</lpage>.</citation>
</ref>
<ref id="bibr14-1538574413478474">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaikof</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Brewster</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Dalman</surname>
<given-names>RL</given-names>
</name>
<etal/>
</person-group>. <article-title>The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines</article-title>. <source>J Vasc Surg</source>. <year>2009</year>;<volume>50</volume>(<issue>suppl 4</issue>):<fpage>S2</fpage>–<lpage>S49</lpage>.</citation>
</ref>
<ref id="bibr15-1538574413478474">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaikof</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Blankensteijn</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>PL</given-names>
</name>
<etal/>
</person-group>. <article-title>Reporting standards for endovascular aortic aneurysm repair</article-title>. <source>J Vasc Surg</source>. <year>2002</year>;<volume>35</volume>(<issue>5</issue>):<fpage>1048</fpage>–<lpage>1060</lpage>.</citation>
</ref>
<ref id="bibr16-1538574413478474">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deaton</surname>
<given-names>DH</given-names>
</name>
</person-group>. <article-title>Future technologies to address the failed endoprosthesis</article-title>. <source>Semin Vasc Surg</source>. <year>2009</year>;<volume>22</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr17-1538574413478474">
<label>17</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Higgins</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Apostol</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ritter</surname>
<given-names>C.</given-names>
</name>
</person-group> <source>Simulation of the Insertion of an Endostaple<sup>TM</sup> into an Vascular Stent and an Artery</source>. <publisher-loc>MedSource Technologies</publisher-loc>; <year>2001</year>. <ext-link ext-link-type="uri" xlink:href="http://www.ansys.com/staticassets/ANSYS/staticassets/resourcelibrary/confpaper/2002-Int-ANSYS-Conf-202.PDF">http://www.ansys.com/staticassets/ANSYS/staticassets/resourcelibrary/confpaper/2002-Int-ANSYS-Conf-202.PDF</ext-link>. <comment>Accessed on 30 Aug 2012</comment>.</citation>
</ref>
<ref id="bibr18-1538574413478474">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Perdikides</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saratzis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saratzis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kiskinis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Deaton</surname>
<given-names>DH</given-names>
</name>
</person-group>. <article-title>Helical EndoStaples enhance endograft fixation in an experimental model using human cadaveric aortas</article-title>. <source>J Vasc Surg</source>. <year>2012</year>;<volume>55</volume>(<issue>6</issue>):<fpage>1726</fpage>–<lpage>1733</lpage>.</citation>
</ref>
<ref id="bibr19-1538574413478474">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trout</surname>
<given-names>HH</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Tanner</surname>
<given-names>HM</given-names>
</name>
</person-group>. <article-title>A new vascular Endostaple: a technical description</article-title>. <source>J Vasc Surg</source>. <year>2001</year>;<volume>34</volume>(<issue>3</issue>):<fpage>565</fpage>–<lpage>568</lpage>.</citation>
</ref>
<ref id="bibr20-1538574413478474">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trout</surname>
<given-names>HH</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Tanner</surname>
<given-names>HM.</given-names>
</name>
</person-group> <article-title>Calf study to examine endostaple-related thrombogenesis and tissure in-growth</article-title>. <source>J Vasc Surg</source>. <year>2009</year>;<volume>50</volume>:<fpage>1542</fpage>.</citation>
</ref>
<ref id="bibr21-1538574413478474">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohtake</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>An experimental study of type I endoleak repair with a suturing device</article-title>. <source>Ann Thorac Surg</source>. <year>2009</year>;<volume>88</volume>(<issue>1</issue>):<fpage>258</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr22-1538574413478474">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Arko</surname>
<given-names>FR</given-names>
</name>
</person-group>. <article-title>Early in vivo analysis of an endovascular stapler during endovascular aneurysm repair</article-title>. <source>Vascular</source>. <year>2009</year>;<volume>17</volume>(<issue>suppl 3</issue>):<fpage>S105</fpage>–<lpage>S110</lpage>.</citation>
</ref>
<ref id="bibr23-1538574413478474">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Deaton</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Condado</surname>
<given-names>JA.</given-names>
</name>
</person-group> <article-title>Aptus endovascular AAA repair system</article-title>. <source>Endovasc Today</source>. <volume>2006</volume>;<fpage>7:29</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr24-1538574413478474">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandhi</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Katzen</surname>
<given-names>BT.</given-names>
</name>
</person-group> <article-title>Treating a type Ia endoleak using EndoAnchors</article-title>. <source>Endovasc Today</source>. <year>2012</year>;<fpage>3:23</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr25-1538574413478474">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Vries</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Schrijver</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Van den Heuvel</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Vos</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Use of endostaples to secure migrated endografts and proximal cuffs after failed endovascular abdominal aortic aneurysm repair</article-title>. <source>J Vasc Surg</source>. <year>2011</year>;<volume>54</volume>(<issue>6</issue>):<fpage>1792</fpage>–<lpage>1794</lpage>.</citation>
</ref>
<ref id="bibr26-1538574413478474">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donas</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Kafetzakis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Umscheid</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tessarek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Torsello</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Vascular endostapling: new concept for endovascular fixation of aortic stent-grafts</article-title>. <source>J Endovasc Ther</source>. <year>2008</year>;<volume>15</volume>(<issue>5</issue>):<fpage>499</fpage>–<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr27-1538574413478474">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donas</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Torsello</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Midterm results of the Anson refix endostapling fixation system for aortic stent-grafts</article-title>. <source>J Endovasc Ther</source>. <year>2010</year>;<volume>17</volume>(<issue>3</issue>):<fpage>320</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr28-1538574413478474">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avci</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vos</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Kolvenbach</surname>
<given-names>RR</given-names>
</name>
<etal/>
</person-group>. <article-title>The use of endoanchors in repair EVAR cases to improve proximal endograft fixation</article-title>. <source>J Cardiovasc Surg (Torino)</source>. <year>2012</year>;<volume>53</volume>(<issue>4</issue>):<fpage>419</fpage>–<lpage>426</lpage>.</citation>
</ref>
<ref id="bibr29-1538574413478474">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deaton</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kasirajan</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>The phase I multicenter trial (STAPLE-1) of the Aptus endovascular repair system: results at 6 months and 1 year</article-title>. <source>J Vasc Surg</source>. <year>2009</year>;<volume>49</volume>(<issue>4</issue>):<fpage>851</fpage>–<lpage>857</lpage>.</citation>
</ref>
<ref id="bibr30-1538574413478474">
<label>30</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Gomero-Cure</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fairman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Henretta</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Glickman</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Deaton</surname>
<given-names>DH.</given-names>
</name>
</person-group> <article-title>Helical Endostaple Fixation Blunts Aortic Neck Dilatation after Endovascular Aortic Aneurysm Repair</article-title>. <conf-name>Vascular Annual Meeting. 2012, June 7-9</conf-name>, <conf-loc>Washington, DC</conf-loc>: <year>2012</year>;<comment>RR18</comment>.</citation>
</ref>
<ref id="bibr31-1538574413478474">
<label>31</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fairman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Deaton</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>WD</given-names>
</name>
</person-group>. <article-title>STAPLE-2: The Pivotal Study of the Aptus Endovascular AAA Repair System - 24 Months Results</article-title>. <conf-name>140 Annual Symposium (Society for Clinical Vascular Surgery). March 14-17, 2012</conf-name>, <conf-loc>Las Vegas Nevada, NV</conf-loc>: <year>2012</year>.</citation>
</ref>
<ref id="bibr32-1538574413478474">
<label>32</label>
<citation citation-type="web">
<collab collab-type="author">National Institutes of Health, ClinicalTrial.gov</collab>. <article-title>The Pivotal Study of the Aptus Endovascular AAA Repair System (STAPLE-2)</article-title>. <ext-link ext-link-type="uri" xlink:href="http://clinicaltrialsgov/ct2/show/NCT00507559">http://clinicaltrialsgov/ct2/show/NCT00507559</ext-link>. <comment>Accessed on 7 May 2012</comment>.</citation>
</ref>
<ref id="bibr33-1538574413478474">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avgerinos</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Dalainas</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kakisis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moulakakis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liapis</surname>
<given-names>CD</given-names>
</name>
</person-group>. <article-title>Endograft accommodation on the aortic bifurcation: an overview of anatomical fixation and implications for long-term stent-graft stability</article-title>. <source>J Endovasc Ther</source>. <year>2011</year>;<volume>18</volume>(<issue>4</issue>):<fpage>462</fpage>–<lpage>470</lpage>.</citation>
</ref>
<ref id="bibr34-1538574413478474">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinster</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Fairman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>BM</given-names>
</name>
</person-group>. <article-title>Late open conversion and explantation of abdominal aortic stent grafts</article-title>. <source>J Vasc Surg</source>. <year>2011</year>;<volume>54</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr35-1538574413478474">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>GJ</given-names>
</name>
</person-group>. <article-title>Endoleaks with the AneuRx graft: a longer-term, single-center study</article-title>. <source>J Vasc Interv Radiol</source>. <year>2011</year>;<volume>22</volume>(<issue>12</issue>):<fpage>1674</fpage>–<lpage>1679</lpage>.</citation>
</ref>
<ref id="bibr36-1538574413478474">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>WG</given-names>
</name>
<name><surname>Guo</surname>
<given-names>DQ</given-names>
</name><etal/></person-group>. <article-title>[Complications in endovascular repair of abdominal aortic aneurysms: treatment and prevention]</article-title>. <source>Zhonghua Wai Ke Za Zhi</source>. <year>2011</year>;<volume>49</volume>(<issue>10</issue>):<fpage>888</fpage>–<lpage>892</lpage>.</citation>
</ref>
<ref id="bibr37-1538574413478474">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weale</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Balasubramaniam</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Macierewicz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hardman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Horrocks</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Outcome and safety of Aorfix stent graft in highly angulated necks—a prospective observational study (arbiter 2)</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>;<volume>41</volume>(<issue>3</issue>):<fpage>337</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr38-1538574413478474">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalteis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Artmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ratzenbock</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lugmayr</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Experience and outcomes after a decade of endovascular abdominal aortic aneurysm repair: a retrospective study from a community-based single center</article-title>. <source>Ann Vasc Surg</source>. <year>2012</year>;<volume>26</volume>(<issue>3</issue>):<fpage>330</fpage>–<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr39-1538574413478474">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stokmans</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Teijink</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Forbes</surname>
<given-names>TL</given-names>
</name>
<etal/>
</person-group>. <article-title>Early Results from the ENGAGE registry: real-world performance of the endurant stent graft for endovascular AAA repair in 1262 patients</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2012</year>;<volume>44</volume>(<issue>4</issue>):<fpage>369</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr40-1538574413478474">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Keulen</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Dekker</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>One-year multicenter results of 100 abdominal aortic aneurysm patients treated with the Endurant stent graft</article-title>. <source>J Vasc Surg</source>. <year>2011</year>;<volume>54</volume>(<issue>3</issue>):<fpage>609</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr41-1538574413478474">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diehm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dick</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Katzen</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Schmidli</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kalka</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Aortic neck dilatation after endovascular abdominal aortic aneurysm repair: a word of caution</article-title>. <source>J Vasc Surg</source>. <year>2008</year>;<volume>47</volume>(<issue>4</issue>):<fpage>886</fpage>–<lpage>892</lpage>.</citation>
</ref>
<ref id="bibr42-1538574413478474">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Verzini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Parlani</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictive factors and clinical consequences of proximal aortic neck dilatation in 230 patients undergoing abdominal aorta aneurysm repair with self-expandable stent-grafts</article-title>. <source>J Vasc Surg</source>. <year>2003</year>;<volume>37</volume>(<issue>6</issue>):<fpage>1200</fpage>–<lpage>1205</lpage>.</citation>
</ref>
<ref id="bibr43-1538574413478474">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dillavou</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Muluk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Makaroun</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Is neck dilatation after endovascular aneurysm repair graft dependent? Results of 4 US phase II trials</article-title>. <source>Vasc Endovascular Surg.</source> <year>2005</year>;<volume>39</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr44-1538574413478474">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diehm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hobo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Influence of pulmonary status and diabetes mellitus on aortic neck dilatation following endovascular repair of abdominal aortic aneurysms: a EUROSTAR report</article-title>. <source>J Endovasc Ther</source>. <year>2007</year>;<volume>14</volume>(<issue>2</issue>):<fpage>122</fpage>–<lpage>129</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>